What is the ticker symbol for Vaxcyte?

Vaxcyte trades under the ticker PCVX on NASDAQ.

What sector does Vaxcyte operate in?

Vaxcyte is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PCVX in a portfolio?

PortView shows PCVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Vaxcyte (PCVX) Stock Analysis

NASDAQHealthcareBiotechnology

$61.30+0.81%

1-year price historyRange $30.89 – $63.30

52-week range$61.30

$30.81$65.00

What Vaxcyte does

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.

Key metrics

Market cap

$8.85B

P/E (TTM)

-8.03

EPS (TTM)

$-7.63

Beta

1.21

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$57.70

200-day avg

$53.85

52-week high

$65.00

52-week low

$30.81

CEO

Grant E. Pickering

ETFs linked to PCVX

Broad-market and Healthcare sector ETFs an investor holding Vaxcyte is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PCVX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PCVX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Vaxcyte?: Vaxcyte trades under the ticker PCVX on NASDAQ.
Which exchange is PCVX listed on?: PCVX is listed on NASDAQ.
What sector does Vaxcyte operate in?: Vaxcyte is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PCVX in a portfolio?: PortView shows PCVX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.